Nā mea hana a me nā mea hoʻolako - hale hana huahana Kina

(1R,2S)-(+)-1-Amino-2-indanol CAS 136030-00-7 Maʻemaʻe ≥98.0% (HPLC) EE ≥98.0% Indinavir Sulfate Intermediate

Inoa Kemika: (1R,2S)-(+)-1-Amino-2-indanol

CAS: 136030-00-7

ʻAno: ʻO ka pauka kristal keʻokeʻo

Maʻemaʻe: ≥98.0% (HPLC)EE: ≥98.0%

Intermediate o Indinavir Sulfate (CAS: 157810-81-6) i ka mālama ʻana i ka maʻi HIV a me ka AIDS

Inquiry: alvin@ruifuchem.com

ninau kikoʻī
(S)-1-Phenyl-1,2,3,4-Tetrahydroisoquinoline CAS 118864-75-8 Maʻemaʻe ≥99.5% Factory

Inoa: (S)-1-Phenyl-1,2,3,4-Tetrahydroisoquinoline

CAS: 118864-75-8

ʻAno: Melemele ʻeleʻele a hiki i ka pauka Crystalline keʻokeʻo

Maʻemaʻe: ≥99.5%Maʻemaʻe Chiral: ≥99.5%

Ka waena o ka API (CAS 242478-38-2) i ka mālama ʻana i ka ʻōpū o Overactive (Pollakiuria)

Enquiry: alvin@ruifuchem.com

ninau kikoʻī
1-Phenyl-1,2,3,4-Tetrahydroisoquinoline CAS 22990-19-8 Assay ≥98.5% (HPLC) Hale Hana

Inoa: 1-Phenyl-1,2,3,4-Tetrahydroisoquinoline

CAS: 22990-19-8

Ke 'ano: Pada Crystal Ke'oke'o

ʻIke: ≥98.5% (HPLC)

ʻIke: 98.5% ~ 101.0% (ma ke kumu maloʻo)

ʻO waena o API (CAS: 242478-38-2) i ka mālama ʻana i ka ʻōpū o Overactive (Pollakiuria)

Enquiry: alvin@ruifuchem.com

ninau kikoʻī
(S)-(+)-3-Quinuclidinol CAS 34583-34-1 Maʻemaʻe ≥99.0% Hale Hana Kiʻekiʻe

Inoa Kemika: (S)-(+)-3-Quinuclidinol

CAS: 34583-34-1

ʻAno: Keʻokeʻo-keʻokeʻo i ka pauka Crystalline keʻokeʻo

Maʻemaʻe: ≥99.0%

ʻIke: 98.0%~102.0% (ma ke kumu Anhydrous)

ʻO waena o API (CAS: 242478-38-2) i ka mālama ʻana i ka ʻōpū o Overactive (Pollakiuria)

Enquiry: alvin@ruifuchem.com

ninau kikoʻī
(R)-(-)-3-Quinuclidinol CAS 25333-42-0 Maʻemaʻe ≥99.0% Maʻemaʻe Chiral ≥99.0%

Inoa Kemika: (R)-(-)-3-Quinuclidinol

CAS: 25333-42-0

ʻAno: Pahu keʻokeʻo a i ʻole keʻokeʻo

Maʻemaʻe: ≥99.0%

Maʻemaʻe Chiral: ≥99.0%

ʻO waena o API (CAS: 242478-38-2) i ka mālama ʻana i ka ʻōpū o Overactive (Pollakiuria)

Enquiry: alvin@ruifuchem.com

ninau kikoʻī
(S)-(-)-3-Chloro-1-Phenyl-1-Propanol CAS 100306-34-1 Maʻemaʻe: ≥98.0% Dapoxetine Hydrochloride Intermediate Factory Maʻemaʻe Kiʻekiʻe

Inoa Kemika: (S)-(-)-3-Chloro-1-Phenyl-1-Propanol

CAS: 100306-34-1

Nānā: Pada Keʻokeʻo

Maʻemaʻe: ≥98.0%

Intermediate o Dapoxetine Hydrochloride (CAS: 129938-20-1) i ka mālama ʻana i ka Premature Ejaculation in Men (PE)

Enquiry: alvin@ruifuchem.com

ninau kikoʻī
(S)-Diphenylprolinol CAS 112068-01-6 Purity ≥99.0% ee ≥99.0% Dapoxetine Hydrochloride Intermediate Factory

Inoa Kemika: (S)-Diphenylprolinol

CAS: 112068-01-6

Nānā: Nā Crystal Keʻokeʻo

Maʻemaʻe: ≥99.0%ee: ≥99.0% (HPLC)

Intermediate o Dapoxetine Hydrochloride (CAS: 129938-20-1) i ka mālama ʻana i ka Premature Ejaculation in Men (PE)

Enquiry: alvin@ruifuchem.com

ninau kikoʻī
(R)-Diphenylprolinol CAS 22348-32-9 Purity ≥99.0% ee ≥99.0% Dapoxetine Hydrochloride Intermediate Factory

Inoa Kemika: (R)-Diphenylprolinol

CAS: 22348-32-9

Nānā: Keʻokeʻo Crystal

Maʻemaʻe: ≥99.0%ee: ≥99.0%

Intermediate o Dapoxetine Hydrochloride (CAS: 129938-20-1) i ka mālama ʻana i ka Premature Ejaculation in Men (PE)

Enquiry: alvin@ruifuchem.com

ninau kikoʻī
(S)-3-Amino-3-Phenylpropanoic Acid CAS 40856-44-8 Purity ≥99.0% ee ≥99.5% Dapoxetine Hydrochloride Intermediate Factory

Inoa Kemika: (S)-3-Amino-3-Phenylpropanoic Acid

Synonyms: (S)-β-Phenylalanine

CAS: 40856-44-8

ʻAno: ʻO ka pauka kristal keʻokeʻo

Maʻemaʻe: ≥99.0%ee: ≥99.5%

Intermediate o Dapoxetine Hydrochloride (CAS: 129938-20-1) i ka mālama ʻana i ka Premature Ejaculation in Men (PE)

Enquiry: alvin@ruifuchem.com

ninau kikoʻī
(S)-3-Amino-3-Phenylpropan-1-ol CAS 82769-76-4 Maʻemaʻe: ≥98.0% Factory Dapoxetine Hydrochloride Intermediate

Inoa Kemika:(S)-3-Amino-3-Phenylpropan-1-ol

CAS: 82769-76-4

ʻAno: Keʻokeʻo a i ʻole-White Crystalline / ʻAʻole ʻulaʻula i Pale Melemele ʻaila wai

Maʻemaʻe: ≥98.0%

Intermediate o Dapoxetine Hydrochloride (CAS: 129938-20-1) i ka mālama ʻana i ka Premature Ejaculation in Men (PE)

Enquiry: alvin@ruifuchem.com

ninau kikoʻī
3-Chloropropiophenone CAS 936-59-4 Maʻemaʻe ≥99.5% (GC) Hale Hana Maʻemaʻe Kiʻekiʻe

Inoa Kemika: 3-Chloropropiophenone

CAS: 936-59-4

ʻO ke ʻano: nā kristal keʻokeʻo a i ʻole ka pauka keʻokeʻo

Maʻemaʻe: ≥99.0% (GC)

Intermediate o Dapoxetine Hydrochloride (CAS: 129938-20-1) i ka mālama ʻana i ka Premature Ejaculation in Men (PE)

Enquiry: alvin@ruifuchem.com

ninau kikoʻī
Palonosetron Hydrochloride CAS 135729-62-3 Maʻemaʻe >99.0% (HPLC) (T) Hale Hana API

Inoa Kemika: Palonosetron Hydrochloride

CAS: 135729-62-3

ʻAno: Keʻokeʻo a i ʻole Keʻokeʻo Crystalline Powder

Maʻemaʻe: >99.0% (HPLC) (T)

ʻO Palonosetron Hydrochloride he mea ikaika loa, koho a me ka waha i ka 5-HT3 receptor antagonist i hoʻohana ʻia i ka pale ʻana a me ka mālama ʻana i ka nausea a me ka luaʻi ʻana o ka chemotherapy (CINV).Antiemetic.

Hoʻokaʻaʻike: Kauka Alvin Huang

Mobile/Wechat/WhatsApp: +86-15026746401

Inquiry: alvin@ruifuchem.com

ninau kikoʻī
1-Naphthoic acid CAS 86-55-5 Maʻemaʻe ≥99.0% (HPLC) Hale Hana Kiʻekiʻe

Inoa Kemika: 1-Naphthoic acid

CAS: 86-55-5

ʻAno: Keʻokeʻo a i ʻole ka pauka keʻokeʻo

Maʻemaʻe: ≥99.0% (HPLC)

ʻO ke kūlana kiʻekiʻe, ka hana kālepa

Enquiry: alvin@ruifuchem.com

ninau kikoʻī
(S)-3-Aminoquinuclidine Dihydrochloride CAS 119904-90-4 Maʻemaʻe ≥99.0% ee≥99.0% Palonosetron Hydrochloride Intermediate

Inoa Kemika: (S)-3-Aminoquinuclidine Dihydrochloride

CAS: 119904-90-4

ʻAno: Keʻokeʻo a me ka Māmā Melemele Crystalline Powder

Maʻemaʻe: ≥98.0%

Ka waena o Palonosetron Hydrochloride (CAS: 135729-62-3) i ka mālama ʻana iā CINV

E-mail: alvin@ruifuchem.com

ninau kikoʻī

<< < Mamua 333 334 335 336 337 338 339 Aʻe >>> ʻAoʻao 336 / 341

Nā huahana

Tetrabutylammonium Fluoride Trihydrate CAS 87749-50-6 Maʻemaʻe >99.0% (Titration)

Tetrabutylammonium Bromide (TBAB) CAS 1643-19-2 Maʻemaʻe >99.0% ((Titration)

Ammonium Bromide CAS 12124-97-9 Maʻemaʻe >99.0% (Titration)

Tetra-n-Octylammonium Bromide (TOAB) CAS 14866-33-2 Maʻemaʻe >98.0% (Titration)

Didodecyldimethylammonium Bromide CAS 3282-73-3 Maʻemaʻe >99.0% (GC)

(S)-(-)-TolBINAP CAS 100165-88-6 Maʻemaʻe >98.0% (HPLC)

Dibromobis(triphenylphosphine)nickel(II) CAS 14126-37-5 Maʻemaʻe >99.0% (GC)

tert-Amyl Alcohol CAS 75-85-4 Maʻemaʻe >99.5% (GC)

tert-Butyl Hydroperoxide (TBHP) (70% i ka wai) CAS 75-91-2

Sodium tert-Butoxide CAS 865-48-5 Maʻemaʻe >99.0% (T)

Lithium tert-Butoxide CAS 1907-33-1 Maʻemaʻe >99.0% (Titration)

Trimethyltetradecylammonium Chloride CAS 4574-04-3 Maʻemaʻe >99.0% (T)

Tributyltin Hydride CAS 688-73-3 Maʻemaʻe >97.0% (GC) Loaʻa iā 0.05% BHT ma ke ʻano he Stabilizer

(1R,2S)-(+)-1-Amino-2-indanol CAS 136030-00-7 Maʻemaʻe ≥98.0% (HPLC) EE ≥98.0% Indinavir Sulfate Intermediate

(S)-1-Phenyl-1,2,3,4-Tetrahydroisoquinoline CAS 118864-75-8 Maʻemaʻe ≥99.5% Factory

1-Phenyl-1,2,3,4-Tetrahydroisoquinoline CAS 22990-19-8 Assay ≥98.5% (HPLC) Hale Hana

(S)-(+)-3-Quinuclidinol CAS 34583-34-1 Maʻemaʻe ≥99.0% Hale Hana Kiʻekiʻe

(R)-(-)-3-Quinuclidinol CAS 25333-42-0 Maʻemaʻe ≥99.0% Maʻemaʻe Chiral ≥99.0%

(S)-(-)-3-Chloro-1-Phenyl-1-Propanol CAS 100306-34-1 Maʻemaʻe: ≥98.0% Dapoxetine Hydrochloride Intermediate Factory Maʻemaʻe Kiʻekiʻe

(S)-Diphenylprolinol CAS 112068-01-6 Purity ≥99.0% ee ≥99.0% Dapoxetine Hydrochloride Intermediate Factory

(R)-Diphenylprolinol CAS 22348-32-9 Purity ≥99.0% ee ≥99.0% Dapoxetine Hydrochloride Intermediate Factory

(S)-3-Amino-3-Phenylpropanoic Acid CAS 40856-44-8 Purity ≥99.0% ee ≥99.5% Dapoxetine Hydrochloride Intermediate Factory

(S)-3-Amino-3-Phenylpropan-1-ol CAS 82769-76-4 Maʻemaʻe: ≥98.0% Factory Dapoxetine Hydrochloride Intermediate

3-Chloropropiophenone CAS 936-59-4 Maʻemaʻe ≥99.5% (GC) Hale Hana Maʻemaʻe Kiʻekiʻe

Palonosetron Hydrochloride CAS 135729-62-3 Maʻemaʻe >99.0% (HPLC) (T) Hale Hana API

1-Naphthoic acid CAS 86-55-5 Maʻemaʻe ≥99.0% (HPLC) Hale Hana Kiʻekiʻe

(S)-3-Aminoquinuclidine Dihydrochloride CAS 119904-90-4 Maʻemaʻe ≥99.0% ee≥99.0% Palonosetron Hydrochloride Intermediate